Sign up to save your podcasts
Or
Share 051 - Amarin Receives UNANIMOUS Recommendation from Advisory Committee
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
051 - Amarin Receives UNANIMOUS Recommendation from Advisory Committee
I'm back! Here are the companies I touch on in this episode (recorded on Nov 14, 2019): Sarepta: 2:30 Trevena: 4:08 Viking: 5:40 Regenxbio: 7:47 Biogen: 12:35 Amarin: 17:38 all of this is only opinion and nothing I have said should be taken as investment advice www.breakingbiotech.com Support Breaking Biotech by donating to their Tip Jar: https://tips.pinecast.com/jar/breaking-biotech
View all episodes
By Matthew Lepoire
4.9
2424 ratings
I'm back! Here are the companies I touch on in this episode (recorded on Nov 14, 2019): Sarepta: 2:30 Trevena: 4:08 Viking: 5:40 Regenxbio: 7:47 Biogen: 12:35 Amarin: 17:38 all of this is only opinion and nothing I have said should be taken as investment advice www.breakingbiotech.com Support Breaking Biotech by donating to their Tip Jar: https://tips.pinecast.com/jar/breaking-biotech